科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2012/10/25 | 1,228 | 1,263 | 1,228 | 1,262 | +34 | +2.8% | 540,000 |
2012/10/24 | 1,225 | 1,229 | 1,210 | 1,228 | +16 | +1.3% | 369,000 |
2012/10/23 | 1,211 | 1,218 | 1,202 | 1,212 | +7 | +0.6% | 204,000 |
2012/10/22 | 1,192 | 1,209 | 1,192 | 1,205 | +6 | +0.5% | 181,000 |
2012/10/19 | 1,210 | 1,215 | 1,197 | 1,199 | -19 | -1.6% | 146,000 |
2012/10/18 | 1,200 | 1,219 | 1,198 | 1,218 | +29 | +2.4% | 280,000 |
2012/10/17 | 1,177 | 1,197 | 1,177 | 1,189 | +21 | +1.8% | 188,000 |
2012/10/16 | 1,172 | 1,176 | 1,162 | 1,168 | -1 | -0.1% | 196,000 |
2012/10/15 | 1,175 | 1,180 | 1,164 | 1,169 | -7 | -0.6% | 156,000 |
2012/10/12 | 1,178 | 1,186 | 1,173 | 1,176 | +6 | +0.5% | 150,000 |
2012/10/11 | 1,157 | 1,178 | 1,154 | 1,170 | +11 | +0.9% | 228,000 |
2012/10/10 | 1,172 | 1,180 | 1,157 | 1,159 | -20 | -1.7% | 189,000 |
2012/10/09 | 1,177 | 1,191 | 1,177 | 1,179 | +3 | +0.3% | 200,000 |
2012/10/05 | 1,180 | 1,193 | 1,174 | 1,176 | +8 | +0.7% | 301,000 |
2012/10/04 | 1,157 | 1,170 | 1,151 | 1,168 | +17 | +1.5% | 229,000 |
2012/10/03 | 1,159 | 1,159 | 1,143 | 1,151 | -8 | -0.7% | 170,000 |
2012/10/02 | 1,166 | 1,168 | 1,156 | 1,159 | -9 | -0.8% | 185,000 |
2012/10/01 | 1,167 | 1,170 | 1,147 | 1,168 | +2 | +0.2% | 261,000 |
2012/09/28 | 1,181 | 1,181 | 1,159 | 1,166 | -11 | -0.9% | 198,000 |
2012/09/27 | 1,161 | 1,184 | 1,161 | 1,177 | +5 | +0.4% | 215,000 |
2012/09/26 | 1,150 | 1,181 | 1,150 | 1,172 | -3 | -0.3% | 224,000 |
2012/09/25 | 1,168 | 1,185 | 1,168 | 1,175 | -7 | -0.6% | 375,000 |
2012/09/24 | 1,190 | 1,198 | 1,177 | 1,182 | -7 | -0.6% | 315,000 |
2012/09/21 | 1,169 | 1,192 | 1,165 | 1,189 | +20 | +1.7% | 327,000 |
2012/09/20 | 1,170 | 1,184 | 1,159 | 1,169 | +4 | +0.3% | 425,000 |
2012/09/19 | 1,177 | 1,177 | 1,155 | 1,165 | +4 | +0.3% | 458,000 |
2012/09/18 | 1,178 | 1,178 | 1,158 | 1,161 | +13 | +1.1% | 406,000 |
2012/09/14 | 1,150 | 1,159 | 1,146 | 1,148 | +6 | +0.5% | 460,000 |
2012/09/13 | 1,136 | 1,143 | 1,133 | 1,142 | +7 | +0.6% | 204,000 |
2012/09/12 | 1,117 | 1,135 | 1,117 | 1,135 | +19 | +1.7% | 262,000 |
2012/09/11 | 1,119 | 1,126 | 1,115 | 1,116 | -3 | -0.3% | 218,000 |
2012/09/10 | 1,114 | 1,119 | 1,110 | 1,119 | +11 | +1% | 138,000 |
2012/09/07 | 1,101 | 1,114 | 1,101 | 1,108 | +11 | +1% | 182,000 |
2012/09/06 | 1,109 | 1,109 | 1,091 | 1,097 | -12 | -1.1% | 260,000 |
2012/09/05 | 1,119 | 1,124 | 1,108 | 1,109 | -10 | -0.9% | 249,000 |
2012/09/04 | 1,117 | 1,122 | 1,113 | 1,119 | +5 | +0.4% | 218,000 |
2012/09/03 | 1,121 | 1,127 | 1,114 | 1,114 | -6 | -0.5% | 154,000 |
2012/08/31 | 1,122 | 1,130 | 1,115 | 1,120 | -4 | -0.4% | 255,000 |
2012/08/30 | 1,118 | 1,126 | 1,117 | 1,124 | +5 | +0.4% | 182,000 |
2012/08/29 | 1,123 | 1,132 | 1,117 | 1,119 | -3 | -0.3% | 137,000 |
2012/08/28 | 1,130 | 1,133 | 1,120 | 1,122 | -8 | -0.7% | 139,000 |
2012/08/27 | 1,135 | 1,138 | 1,129 | 1,130 | +1 | +0.1% | 125,000 |
2012/08/24 | 1,127 | 1,131 | 1,123 | 1,129 | +2 | +0.2% | 160,000 |
2012/08/23 | 1,128 | 1,130 | 1,121 | 1,127 | +4 | +0.4% | 257,000 |
2012/08/22 | 1,116 | 1,125 | 1,110 | 1,123 | +7 | +0.6% | 199,000 |
2012/08/21 | 1,114 | 1,127 | 1,114 | 1,116 | +5 | +0.5% | 217,000 |
2012/08/20 | 1,109 | 1,119 | 1,108 | 1,111 | -4 | -0.4% | 182,000 |
2012/08/17 | 1,125 | 1,127 | 1,111 | 1,115 | -5 | -0.4% | 259,000 |
2012/08/16 | 1,126 | 1,132 | 1,117 | 1,120 | -6 | -0.5% | 238,000 |
2012/08/15 | 1,126 | 1,127 | 1,120 | 1,126 | ±0 | ±0% | 60,000 |
3101~
3150
件表示中 / 3734件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 379,600円 | -6.4% | -71.8% | 5.01% | 42.40倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 398,500円 | +3.6% | +6.1% | 3.01% | 13.42倍 | 0.79倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
ジーエヌアイ | 312,000円 | +21.7% | +999.9% | 0.00% | 13.07倍 | 4.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
サンバイオ | 216,100円 | - | - | 0.00% | - | 100.09倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム